Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial.
EClinicalMedicine
View this publicationEClinicalMedicine
View this publicationUnited European gastroenterology journal
View this publicationNature communications
View this publicationPharmaceutics
View this publicationCells
View this publicationPathogens (Basel, Switzerland)
View this publicationNutrients
View this publicationEuropean journal of immunology
View this publicationHamostaseologie
View this publicationRheumatology (Oxford, England)
View this publication